Partial or Complete Excavation of Deep Caries in Primary Molars
Launched by KAROLINSKA INSTITUTET · Nov 1, 2020
Trial Information
Current as of May 14, 2025
Unknown status
Keywords
ClinConnect Summary
The treatment of carious lesions with risk for progression has traditionally been done with caries removal and restorative treatment of the affected teeth. In primary teeth, different treatments for deep carious lesions have been described. Complete excavation aims to removing all infected and demineralised dentin with a high risk of pulpal exposure, postoperative complications and thus the risk of the teeth being lost. In many cases, treatment also involves pain and suffering for the patient, which can lead to dental fear among children.
In latest years there has been a growing evidence f...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children in the age of 3-8 years, with one or more primary molar teeth in a need of a restoration due to a moderate depth of carious lesion;
- • caries lesion diagnosed into dentin on radiographs though not exceeding the inner third of the dentin
- • caries lesion diagnosed visually with a cavity into dentin.
- Exclusion Criteria:
- • Children with behaviour management problems.
- • Teeth with pulpal symptoms
- • Teeth expected to exfoliate within the next 18 months
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Huddinge, Stockholm, Sweden
Patients applied
Trial Officials
Göran Dahllöf, Professor
Principal Investigator
Department of Dental Medicine, Karolinska Institutet, Sweden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials